What is the share price of Amerise Biosciences Ltd (AMERISE) today?
The share price of AMERISE as on 10th July 2025 is ₹0.79. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Amerise Biosciences Ltd (AMERISE) share?
The past returns of Amerise Biosciences Ltd (AMERISE) share are- Past 1 week: -4.76%
- Past 1 month: -8.05%
- Past 3 months: -11.24%
- Past 6 months: -31.90%
- Past 1 year: 6.76%
- Past 3 years: -23.30%
- Past 5 years: -10.23%
What are the peers or stocks similar to Amerise Biosciences Ltd (AMERISE)?
The peers or stocks similar to Amerise Biosciences Ltd (AMERISE) include:What is the market cap of Amerise Biosciences Ltd (AMERISE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Amerise Biosciences Ltd (AMERISE) is ₹5.22 Cr as of 10th July 2025.What is the 52 week high and low of Amerise Biosciences Ltd (AMERISE) share?
The 52-week high of Amerise Biosciences Ltd (AMERISE) is ₹1.45 and the 52-week low is ₹0.62.What is the PE and PB ratio of Amerise Biosciences Ltd (AMERISE) stock?
The P/E (price-to-earnings) ratio of Amerise Biosciences Ltd (AMERISE) is 521.95. The P/B (price-to-book) ratio is 0.97.Which sector does Amerise Biosciences Ltd (AMERISE) belong to?
Amerise Biosciences Ltd (AMERISE) belongs to the Materials sector & Wood Products sub-sector.How to buy Amerise Biosciences Ltd (AMERISE) shares?
You can directly buy Amerise Biosciences Ltd (AMERISE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Amerise Biosciences Ltd
AMERISE Share Price
AMERISE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
AMERISE Performance & Key Metrics
AMERISE Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 0.97 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
27.93 | 3.47 | 1.60% |
AMERISE Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
AMERISE Company Profile
Amerise Biosciences Ltd is currently inactive and did not generate any revenue.
AMERISE Forecast
AMERISE Forecasts
AMERISE
AMERISE
Income
Balance Sheet
Cash Flow
AMERISE Income Statement
AMERISE Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.00 | 0.00 | 1.18 | 0.00 | — | 9.58 | 0.01 | 0.04 | 0.19 | 0.19 | ||||||||||
Raw Materials | — | — | — | — | — | — | — | — | 0.18 | 0.19 | ||||||||||
Power & Fuel Cost | — | — | — | — | — | — | — | — | ||||||||||||
Employee Cost | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 | 0.05 | 0.02 | 0.07 | ||||||||||||
Selling & Administrative Expenses | — | — | — | — | — | — | — | — | ||||||||||||
Operating & Other expenses | 0.93 | 0.01 | 1.16 | 0.11 | 0.13 | 8.97 | 0.11 | 0.11 | ||||||||||||
EBITDA | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | 0.01 | — | ||||||||||
Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
PBIT | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | 0.01 | — | ||||||||||
Interest & Other Items | — | — | — | — | — | — | — | — | — | — | ||||||||||
PBT | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | 0.01 | — | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
Net Income | -0.94 | -0.02 | 0.01 | -0.15 | -0.17 | 0.56 | -0.12 | -0.14 | 0.01 | — | ||||||||||
EPS | -0.14 | -0.00 | 0.00 | -0.02 | -0.03 | 0.08 | -0.02 | -0.02 | 0.00 | 0.00 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
AMERISE Company Updates
AMERISE Stock Peers
AMERISE Past Performance & Peer Comparison
AMERISE Past Performance & Peer Comparison
MaterialsWood Products
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Amerise Biosciences Ltd | 521.95 | 0.97 | — |
Century Plyboards (India) Ltd | 88.08 | 7.40 | 0.14% |
Greenply Industries Ltd | 42.09 | 5.43 | 0.16% |
Greenpanel Industries Ltd | 48.02 | 2.63 | 0.11% |
AMERISE Stock Price Comparison
Compare AMERISE with any stock or ETFAMERISE Holdings
AMERISE Shareholdings
AMERISE Promoter Holdings Trend
AMERISE Promoter Holdings Trend
AMERISE Institutional Holdings Trend
AMERISE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
AMERISE Shareholding Pattern
AMERISE Shareholding Pattern
AMERISE Shareholding History
AMERISE Shareholding History
smallcases containing AMERISE stock
smallcases containing AMERISE stock
Looks like this stock is not in any smallcase yet.
AMERISE Events
AMERISE Events
AMERISE Dividend Trend
AMERISE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
AMERISE Dividend Trend
AMERISE has not given any dividends in last 5 years
AMERISE Dividends
AMERISE Dividends
AMERISE Stock News & Opinions
AMERISE Stock News & Opinions
Net profit of Amerise Biosciences rose 450.00% to Rs 0.11 crore in the quarter ended March 2025 as against Rs 0.02 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit reported to Rs 0.01 crore in the year ended March 2025 as against net loss of Rs 0.15 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 19 May 2025.Powered by Capital Market - Live
Net Loss of Amerise Biosciences reported to Rs 0.02 crore in the quarter ended December 2024 as against net loss of Rs 0.06 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 3 February 2025.Powered by Capital Market - Live
Net Loss of Amerise Biosciences reported to Rs 0.03 crore in the quarter ended September 2024 as against net loss of Rs 0.04 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 22 October 2024.Powered by Capital Market - Live
Amerise Biosciences announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net Loss of Amerise Biosciences reported to Rs 0.05 crore in the quarter ended June 2024 as against net loss of Rs 0.07 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
Amradeep Industries renames as ‘Amerise Biosciences’
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant